ROCKVILLE, Md. and CHESTERBROOK, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ:CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases, today …
VANCOUVER, British Columbia, March 01, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it has …
CRESSKILL, N.J. and JERUSALEM, March 01, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders, today announced the closing of its …
NEW HAVEN, Conn., March 01, 2021 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biopharmaceutical company creating a new class of drugs based on targeted protein degradation, today reported financial results for the fourth quarter and …
WOODSIDE, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Leading employee experience platform, Socrates.ai, today shared details of its escalating market momentum. Delivering one seamless digital conversation destination for anything the workforce wants to ask …
CHICAGO and VANCOUVER, British Columbia, March 01, 2021 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ retail stores, today announced …
Expands its popular i.MX applications processor continuum with ultra-low power i.MX 8ULP, Microsoft Azure Sphere-certified i.MX 8ULP-CS and the next generation of scalable, high-performance i.MX 9 applications processors Provides a giant leap in security …
ORLANDO, Fla., March 01, 2021 (GLOBE NEWSWIRE) -- PlanSource, the technology company that automates and simplifies employee benefits programs, today shared a recap of 2020 and its direction for 2021. More than 1,000 new employers representing 1.6 million …
-New STS101 Phase 3 efficacy trial planned to begin mid-2021 with topline results expected second half of 2022- -Proceeds from $80 million private placement and existing cash expected to fund operations into second half of 2023- -Conference call this …
Jay S. Hennick agrees to continue as Chairman, Chief Executive Officer and Largest Voting Shareholder Largest independent shareholder, holding 14.7% of the outstanding Subordinate Voting Shares, confirms support of Transaction TORONTO, March 01, 2021 ( …
NEW HAVEN, Conn., March 01, 2021 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. ("BioXcel" or the "Company") (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop …
CHESTERBROOK, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced …
Fourth quarter net sales up 34% and Annual net sales up 40% Fourth quarter earnings per share (diluted) increased 295% to $0.79 Net Sales and Year-End backlogs, excluding increases from PPE sales are the highest ever recorded Annual debt reduction of $31.6 …
2020 Total Galafold Revenue of $260.9M; Increased 43 Percent Year-on-Year Continued Strong Global Growth of Galafold Expected in 2021 with Revenue of $300M-$315M AT-GAA Rolling BLA Submission in Pompe Disease Planned for Completion in 2Q21 and …
AGOURA HILLS, California, March 01, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and infectious disease and respiratory health, and Windlas Biotech Pvt. Ltd. (Windlas), a …
SOUTH SAN FRANCISCO, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA) a clinical-stage biopharmaceutical company, today announced that it has agreed to sell 14,084,507 shares of its common stock to certain …
Company to host conference call today at 8:00 AM Eastern NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) …
HORSHAM, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today …
Conference call and webcast scheduled for today at 8:00 a.m. ET BUFFALO, N.Y., March 01, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel …
-- Company to Host Conference Call and Webcast Today at 8:00 a.m. ET SHANGHAI and SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today reported …
04 days 23:37:19
